How to buy Syneos Health shares

Learn how to easily invest in Syneos Health shares.

Syneos Health Inc (SYNH) is a publicly traded diagnostics and research business based in the US which employs around 28,750 staff. Syneos Health is listed on the NASDAQ and traded in US dollars.

How to buy shares in Syneos Health

  1. Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
  2. Fund your account. Add money to your account via bank transfer, debit card or credit card.
  3. Search the platform by ticker symbol. SYNH in this case.
  4. Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
  5. Submit the order. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy Syneos Health shares

Best for 0% commission stocks
eToro logo
Finder Award
Go to site
Capital at risk. T&Cs apply.
Copy picks from top traders
Commission-free trades
Fractional shares
Get dividend payments
Best for fractional shares
XTB logo
Go to site
Capital at risk. T&Cs apply.
Earn 4.75% on uninvested funds
Commission-free trades
Fractional shares
5,400+ stocks/ETFs
Best for customer satisfaction
Hargreaves Lansdown logo
Finder Award
Go to site
Capital at risk. T&Cs apply.
97% would recommend
Free fund trading
Expert insights
Wide range of accounts

Share dealing platform comparison

Table: sorted by promoted deals first
Product UKFST Finder Score Min. initial deposit Price per trade Frequent trader rate Platform fees Offer Link
eToro
Finder AwardFree Trades
eToro logo
$100
£0 on stocks
N/A
£0
Go to site

Capital at risk

Platform details
Freetrade
Free TradesOffer
Freetrade logo
£1
£0
N/A
£0
Get a free share worth up to £100 when you sign up and deposit at least £50. T&Cs apply. Capital at risk.
Go to site

Capital at risk

Platform details
Trading212
Free TradesOffer
Trading212 logo
£1
£0
£0
£0
Get free fractional shares worth up to £100 when you sign up with Finder’s link and use the code “FINDER”. T&Cs apply. Capital at risk.
Go to site

Capital at risk

Platform details
XTB
Free Trades
XTB logo
£0
£0
£0
£0
Earn up to 4.75% interest on uninvested cash.
Go to site

Capital at risk

Platform details
CMC Invest
Finder Award
CMC Invest logo
£0
£0
N/A
£0
Get your first 3 months free when you upgrade to Plus plan. T&Cs apply. Capital at risk.
Go to site

Capital at risk

Platform details
loading

Finder Score for trading platforms

To make comparing even easier we came up with the Finder Score. Costs, features, ease and range of investments across 30+ platforms are all weighted and scaled to produce a score out of 10. The higher the score the better the platform – simple.

Read the full methodology
These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Alternative ways to invest in Syneos Health

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Syneos Health), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

Syneos Health is a major part of the NASDAQ, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

Is it a good time to buy Syneos Health stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View Syneos Health's price performance, share price volatility, historical data and technicals.

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro
Invest in Syneos Health shares
Finder AwardFree Trades
  • Over 5,500+ stocks from 20 exchanges
  • Free to open an account
  • Commission-free trading

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Is Syneos Health under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Syneos Health P/E ratio, PEG ratio and EBITDA.

Syneos Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, Syneos Health's shares trade at around 61x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Syneos Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2799. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Syneos Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Syneos Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $587.5 million (£469.6 million).

The EBITDA is a measure of Syneos Health's overall financial performance and is widely used to measure a its profitability.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


More guides on Finder

Go to site